Park J H, Richards C H, McMillan D C, Horgan P G, Roxburgh C S D
Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
Ann Oncol. 2014 Mar;25(3):644-651. doi: 10.1093/annonc/mdt593. Epub 2014 Jan 23.
Tumour stroma percentage (TSP) has previously been reported to predict survival in patients with colorectal cancer (CRC); however, whether this is independent of other aspects of the tumour microenvironment is unknown. In the present study, the relationship between TSP, the tumour microenvironment and survival was examined in patients undergoing elective, curative CRC resection.
Patients undergoing resection at a single centre (1997-2008) were identified from a prospective database. TSP was measured at the invasive margin and its association with cancer-specific survival (CSS) and clinicopathological characteristics examined.
Three hundred and thirty-one patients were included in the analysis. TSP was associated with CSS in patients with stage I-III disease [hazard ratio (HR) 1.84, 95% confidence interval (CI) 1.17-2.92, P = 0.009], independent of age, systemic inflammation, N stage, venous invasion and Klintrup-Mäkinen score. Furthermore, TSP was associated with reduced CSS in patients with node-negative disease (HR 2.14, 95% CI 1.01-4.54, P = 0.048) and those who received adjuvant chemotherapy (HR 2.83, 95% CI 1.23-6.53, P = 0.015), independent of venous invasion and host inflammatory responses. TSP was associated with several adverse pathological characteristics, including advanced T and N stage. Furthermore, TSP was associated with an infiltrative invasive margin and inversely associated with necrosis.
The TSP was a significant predictor of survival in patients undergoing elective, curative CRC resection, independent of adverse pathological characteristics and host inflammatory responses. In addition, TSP was strongly associated with local tumour growth and invasion.
先前有报道称肿瘤基质百分比(TSP)可预测结直肠癌(CRC)患者的生存情况;然而,其是否独立于肿瘤微环境的其他方面尚不清楚。在本研究中,对接受择期根治性CRC切除术的患者,研究了TSP、肿瘤微环境与生存之间的关系。
从一个前瞻性数据库中识别出在单一中心(1997 - 2008年)接受手术切除的患者。在浸润边缘测量TSP,并检查其与癌症特异性生存(CSS)及临床病理特征的关联。
331例患者纳入分析。TSP与I - III期疾病患者的CSS相关[风险比(HR)1.84,95%置信区间(CI)1.17 - 2.92,P = 0.009],独立于年龄、全身炎症、N分期、静脉侵犯和克林特鲁普 - 马基宁评分。此外,TSP与无淋巴结转移疾病患者的CSS降低相关(HR 2.14,95% CI 1.01 - 4.54,P = 0.048)以及与接受辅助化疗的患者相关(HR 2.83,95% CI 1.23 - 6.53,P = 0.015),独立于静脉侵犯和宿主炎症反应。TSP与多种不良病理特征相关,包括T和N分期进展。此外,TSP与浸润性浸润边缘相关,与坏死呈负相关。
TSP是接受择期根治性CRC切除术患者生存的重要预测指标,独立于不良病理特征和宿主炎症反应。此外,TSP与局部肿瘤生长和侵袭密切相关。